e-Health ethics code to be finalized in May
There is still time to file comments on the International e-Health Ethics Code, written as a result of the Internet Health Coalition’s Ethics Summit, which took place in early February. According
There is still time to file comments on the International e-Health Ethics Code, written as a result of the Internet Health Coalitions Ethics Summit, which took place in early February. According to Dr. Helga Rippin, IHC chair, approximately 50 sets of comments have been filed as of early April. The proposed code addresses issues like the quality of information offered via the Internet, best commercial practices, and best practices for providing healthcare on the Internet. IHC intends the code to provide guidelines for e-Health and to raise the bar for professional behavior on the Internet. Once the code is final, IHC plans to develop an accreditation or implementation vehicle to ensure that the code is used. According to Rippin, IHC is also working on obtaining formal endorsements for the final document from vendors, government agencies, and special-interest groups all over the world.
IHC started its Internet ethics initiative in response to a challenge issued by Dr. George Lundberg, editor of Medscape, in October 1999. Various entities, including healthcare vendors, dot.coms, consumer groups, and government agencies participated in the summit. IHC issued 50 invitations, 25 by lottery. Following the summit, IHC published the draft code on Feb. 18. The draft code is available on the Web. IHC is accepting comments through the beginning of May.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
